Last 7 days
-7.2%
Last 30 days
-37.4%
Last 90 days
-28.7%
Trailing 12 Months
-84.3%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABBV | 279.9B | 58.1B | 4.88% | 1.38% | 23.64 | 4.82 | 3.30% | 2.55% |
REGN | 87.7B | 12.2B | 9.61% | 20.63% | 20.21 | 7.2 | -24.26% | -46.28% |
VRTX | 80.8B | 8.9B | 6.80% | 24.91% | 24.32 | 9.05 | 17.91% | 41.84% |
INCY | 15.6B | 3.4B | -10.55% | -10.18% | 45.92 | 4.61 | 13.67% | -64.09% |
MID-CAP | ||||||||
NTRA | 6.3B | 820.2M | 18.24% | 39.36% | -11.51 | 7.68 | 31.13% | -16.13% |
ARWR | 2.6B | 278.3M | -26.06% | -48.44% | -16.69 | 9.26 | 92.72% | 15.56% |
SMALL-CAP | ||||||||
VCYT | 1.6B | 296.5M | -8.08% | -20.51% | -43.24 | 5.33 | 35.09% | 51.62% |
CSTL | 597.7M | 137.0M | -4.54% | -49.04% | -8.9 | 4.36 | 45.65% | -114.55% |
CDNA | 479.1M | 321.8M | -36.12% | -76.84% | -6.25 | 1.49 | 8.57% | -149.86% |
NVTA | 316.8M | 516.3M | -37.38% | -84.33% | -0.1 | 0.61 | 12.13% | -719.59% |
ORGO | 247.4M | 450.9M | -24.70% | -74.25% | 15.93 | 0.55 | -3.52% | -83.51% |
CELC | 142.1M | - | -18.72% | 19.47% | -4 | - | - | -39.92% |
OPGN | 3.6M | 3.3M | 31.86% | 93.51% | -0.11 | 1.09 | -21.77% | 4.40% |
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -0.7% | 516,303,000 | 519,970,000 | 500,829,000 | 480,519,000 | 460,449,000 |
S&GA Expenses | -6.6% | 218,881,000 | 234,291,000 | 240,599,000 | 234,814,000 | 225,910,000 |
R&D Expenses | -13.0% | 402,088,000 | 462,323,000 | 472,657,000 | 463,965,000 | 416,087,000 |
EBITDA | 4.0% | -2,952,379,000 | -3,074,270,000 | -2,995,039,000 | -400,734,000 | - |
EBITDA Margin | 3.3% | -5.72 | -5.91 | -5.98 | -0.83 | - |
Earnings Before Taxes | 3.3% | -3,151,197,000 | -3,258,800,000 | -3,160,600,000 | -516,350,000 | -415,863,000 |
EBT Margin | 2.6% | -6.10 | -6.27 | -6.31 | -1.07 | - |
Interest Expenses | 1.0% | 56,747,000 | 56,180,000 | 56,104,000 | 55,492,000 | 49,900,000 |
Net Income | 3.3% | -3,106,293,000 | -3,211,600,000 | -3,108,620,000 | -451,373,000 | -379,006,000 |
Net Income Margin | 2.6% | -6.02 | -6.18 | -6.21 | -0.94 | - |
Free Cahsflow | 16.5% | -546,270,000 | -654,424,000 | -694,738,000 | -686,975,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -3.6% | 1,954 | 2,026 | 2,291 | 4,768 | 4,920 |
Current Assets | -5.0% | 693 | 730 | 894 | 1,031 | 1,179 |
Cash Equivalents | 18.6% | 257 | 217 | 304 | 325 | 923 |
Inventory | 1.6% | 30.00 | 30.00 | 49.00 | 43.00 | 34.00 |
Net PPE | -4.5% | 109 | 114 | 133 | 130 | 115 |
Goodwill | NaN% | - | - | - | 2,283 | 2,283 |
Liabilities | -0.8% | 1,852 | 1,867 | 1,905 | 1,924 | 1,941 |
Current Liabilities | -4.6% | 108 | 113 | 139 | 168 | 144 |
Shareholder's Equity | -35.9% | 102 | 159 | 386 | 2,844 | 2,978 |
Retained Earnings | -2.1% | -4,829 | -4,729 | -4,428 | -1,904 | -1,722 |
Additional Paid-In Capital | 0.9% | 4,931 | 4,889 | 4,815 | 4,749 | 4,701 |
Accumulated Depreciation | 25.5% | 75.00 | 60.00 | 54.00 | 48.00 | - |
Shares Outstanding | 3.2% | 246 | 238 | 232 | 228 | 228 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 16.0% | -492 | -586 | -623 | -617 | -559 |
Share Based Compensation | -6.3% | 199 | 213 | 178 | 168 | 180 |
Cashflow From Investing | -38.5% | -174 | -126 | -190 | -379 | -204 |
Cashflow From Financing | -78.5% | 2.00 | 8.00 | 9.00 | 1,129 | 1,566 |
100%
100%
86.5%
Y-axis is the maximum loss one would have experienced if Invitae was unfortunately bought at previous high price.
-24.1%
-28.7%
-52.6%
FIve years rolling returns for Invitae.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -68.58 | -156,329 | 48,671 | -% |
2023-03-10 | BAILLIE GIFFORD & CO | unchanged | - | -512 | 1,488 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -96.14 | -3,000 | - | -% |
2023-03-02 | OLIVER LAGORE VANVALIN INVESTMENT GROUP | unchanged | - | 93.00 | 93.00 | -% |
2023-02-28 | Voya Investment Management LLC | added | 5.89 | -44,317 | 179,683 | -% |
2023-02-21 | MACQUARIE GROUP LTD | sold off | -100 | -9,000 | - | -% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 188 | 134 | 134 | -% |
2023-02-16 | AXXCESS WEALTH MANAGEMENT, LLC | reduced | -28.71 | -53,929 | 63,071 | -% |
2023-02-16 | HARBOUR INVESTMENTS, INC. | unchanged | - | 372 | 372 | -% |
2023-02-15 | Seaport Global Advisors, LLC | reduced | -41.39 | -42,893 | 34,107 | 0.12% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | casdin capital, llc | 3.72% | 9,038,388 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.30% | 22,587,955 | SC 13G/A | |
Feb 03, 2023 | sumitomo mitsui trust holdings, inc. | 7.10% | 17,256,161 | SC 13G/A | |
Jan 25, 2023 | blackrock inc. | 9.0% | 21,768,046 | SC 13G | |
Feb 14, 2022 | baker bros. advisors lp | 4.4% | 9,873,488 | SC 13G/A | |
Feb 14, 2022 | nikko asset management americas, inc. | 8.39% | 18,998,453 | SC 13G/A | |
Feb 14, 2022 | casdin capital, llc | 5.39% | 12,203,669 | SC 13G/A | |
Feb 09, 2022 | ark investment management llc | 11.80% | 26,700,813 | SC 13G/A | |
Feb 04, 2022 | sumitomo mitsui trust holdings, inc. | 8.39% | 18,998,453 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.7% | 17,484,785 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | 0.23 -82.17% | 1.23 -4.65% | 3.09 139.53% | 6.84 430.23% |
Current Inflation | 0.02 -98.45% | 0.17 -86.82% | 1.05 -18.60% | 2.65 105.43% | 5.86 354.26% |
Very High Inflation | - - | 0.10 -92.25% | 0.83 -35.66% | 2.14 65.89% | 4.73 266.67% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 17, 2023 | S-3 | S-3 | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 15, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 8-K | Current Report | |
Mar 08, 2023 | 8-K | Current Report | |
Mar 01, 2023 | 8-K | Current Report | |
Mar 01, 2023 | POS AM | POS AM | |
Mar 01, 2023 | POS AM | POS AM |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-13 | Nussbaum Robert L | sold | -3,701 | 1.41 | -2,625 | chief medical officer |
2023-03-13 | Wen Yafei | sold | -3,701 | 1.41 | -2,625 | chief financial officer |
2023-03-13 | Knight Kenneth D. | sold | -2,612 | 1.41 | -1,853 | chief executive officer |
2023-03-13 | Brida Thomas | sold | -3,701 | 1.41 | -2,625 | see remarks |
2023-01-26 | Osborne William H | acquired | - | - | 70,423 | - |
2022-12-19 | George Sean E | sold | -23,210 | 2.0792 | -11,163 | - |
2022-12-16 | George Sean E | sold | -91,420 | 2.0399 | -44,816 | - |
2022-08-25 | WERNER ROBERT F. | sold | -4,657 | 3.45 | -1,350 | chief accounting officer |
2022-08-22 | Nussbaum Robert L | acquired | - | - | 54,000 | chief medical officer |
2022-08-22 | Wen Yafei | acquired | - | - | 102,000 | chief financial officer |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue: | |||
Total revenue | $ 516,303 | $ 460,449 | $ 279,598 |
Operating expenses: | |||
Cost of revenue | 417,256 | 348,669 | 198,275 |
Research and development | 402,088 | 416,087 | 240,605 |
Selling and marketing | 218,881 | 225,910 | 168,317 |
General and administrative | 192,314 | 248,070 | 270,029 |
Goodwill and IPR&D impairment | 2,313,047 | 0 | 0 |
Restructuring and other costs | 140,331 | 0 | 0 |
Gain on sale of RUO kit assets | (47,354) | 0 | 0 |
Change in fair value of contingent consideration | (1,850) | (386,646) | 54,544 |
Total operating expenses | 3,634,713 | 852,090 | 931,770 |
Loss from operations | (3,118,410) | (391,641) | (652,172) |
Other income (expense), net: | |||
Change in fair value of acquisition-related liabilities | 15,906 | 25,196 | (37,527) |
Other income, net | 8,054 | 482 | 5,195 |
Total other income (expense), net | 23,960 | 25,678 | (32,332) |
Interest expense | (56,747) | (49,900) | (29,766) |
Net loss before taxes | (3,151,197) | (415,863) | (714,270) |
Income tax benefit | 44,904 | 36,857 | 112,100 |
Net loss | $ (3,106,293) | $ (379,006) | $ (602,170) |
Net loss per share, basic (in dollars per share) | $ (13.18) | $ (1.80) | $ (4.47) |
Net loss per share, diluted (in dollars per share) | $ (13.18) | $ (1.80) | $ (4.47) |
Shares used in computing net loss per share, basic (in shares) | 235,676,000 | 210,946,000 | 134,587,000 |
Shares used in computing net loss per share, diluted (in shares) | 235,676,000 | 210,946,000 | 134,587,000 |
Test revenue | |||
Revenue: | |||
Total revenue | $ 500,560 | $ 444,072 | $ 272,310 |
Data/services | |||
Revenue: | |||
Total revenue | $ 15,743 | $ 16,377 | $ 7,288 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 257,489 | $ 923,250 |
Marketable securities | 289,611 | 122,121 |
Accounts receivable | 96,148 | 66,227 |
Inventory | 30,386 | 33,516 |
Prepaid expenses and other current assets | 19,496 | 33,691 |
Total current assets | 693,130 | 1,178,805 |
Property and equipment, net | 108,723 | 114,714 |
Operating lease assets | 106,563 | 121,169 |
Restricted cash | 10,030 | 10,275 |
Intangible assets, net | 1,012,549 | 1,187,994 |
Goodwill | 0 | 2,283,059 |
Other assets | 23,121 | 23,551 |
Total assets | 1,954,116 | 4,919,567 |
Current liabilities: | ||
Accounts payable | 13,984 | 21,127 |
Accrued liabilities | 74,388 | 106,453 |
Operating lease obligations | 14,600 | 12,359 |
Finance lease obligations | 5,121 | 4,156 |
Total current liabilities | 108,093 | 144,095 |
Operating lease obligations, net of current portion | 134,386 | 124,369 |
Finance lease obligations, net of current portion | 3,780 | 5,683 |
Debt | 122,333 | 113,391 |
Convertible senior notes, net | 1,470,783 | 1,464,138 |
Deferred tax liability | 8,130 | 51,696 |
Other long-term liabilities | 4,775 | 37,797 |
Total liabilities | 1,852,280 | 1,941,169 |
Commitments and contingencies (Note 8) | ||
Preferred stock, $0.0001 par value: 20,000 shares authorized; nil shares issued and outstanding as of December 31, 2022 and 2021, respectively | 0 | 0 |
Stockholders’ equity: | ||
Common stock, $0.0001 par value: 600,000 and 400,000 shares authorized; 245,562 and 228,116 shares issued and outstanding as of December 31, 2022 and 2021, respectively | 25 | 23 |
Accumulated other comprehensive loss | (80) | (7) |
Additional paid-in capital | 4,931,032 | 4,701,230 |
Accumulated deficit | (4,829,141) | (1,722,848) |
Total stockholders’ equity | 101,836 | 2,978,398 |
Total liabilities and stockholders’ equity | $ 1,954,116 | $ 4,919,567 |